| # | Drug | Count |
|---|---|---|
| 0 | SUNITINIB MALATE | 14 |
| 1 | LEVOTHYROXINE SODIUM | 12 |
| 2 | ADALIMUMAB | 11 |
| 3 | CALCIUM | 10 |
| 4 | ACETAMINOPHEN | 9 |
| 5 | PANTOPRAZOLE | 9 |
| 6 | RIVAROXABAN | 7 |
| 7 | ACETAMINOPHEN 500MG | 6 |
| 8 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 6 |
| 9 | ERGOCALCIFEROL | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROQUINONE | 5 | 0.0084 |
| 1 | VANDETANIB | 5 | 0.0028 |
| 2 | ZIV-AFLIBERCEPT | 2 | 0.0015 |
| 3 | MITOMYCIN | 4 | 0.0011 |
| 4 | CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, URANIUM NITRICUM, X-RAY | 1 | 0.0010 |
| 5 | CALCIUM POLYCARBOPHIL | 2 | 0.0007 |
| 6 | INFLIXIMAB-DYYB | 2 | 0.0006 |
| 7 | SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE | 2 | 0.0005 |
| 8 | ADALIMUMAB-AFZB | 1 | 0.0004 |
| 9 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 13 |
| 1 | Corticosteroid [EPC] | 11 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 11 |
| 3 | Osmotic Laxative [EPC] | 11 |
| 4 | Calcium [EPC] | 10 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 10 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 10 |
| 7 | Benzodiazepine [EPC] | 9 |
| 8 | Factor Xa Inhibitor [EPC] | 8 |
| 9 | Atypical Antipsychotic [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sucrose-specific Enzyme [EPC] | 1 | 0.0055 |
| 1 | Melanin Synthesis Inhibitor [EPC] | 5 | 0.0044 |
| 2 | Ileal Bile Acid Transporter Inhibitor [EPC] | 1 | 0.0022 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 4 | Oxytocic [EPC] | 1 | 0.0003 |
| 5 | Photoenhancer [EPC] | 1 | 0.0003 |
| 6 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 7 | Prostaglandin E1 Analog [EPC] | 3 | 0.0002 |
| 8 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 9 | GLP-2 Analog [EPC] | 2 | 0.0001 |